Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study

ABSTRACT:

SUBMITTER: Bourlon M 

PROVIDER: S-EPMC12331508 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature